Journal Mobile Options
Table of Contents
Vol. 3, No. 2, 2010
Issue release date: April 2010
Obes Facts 2010;3:93–100
(DOI:10.1159/000301785)
Original Article

Effect of Long-Term Whole Body Vibration Training on Visceral Adipose Tissue: A Preliminary Report

Vissers D.a,b,c · Verrijken A.b,c · Mertens I.c · Van Gils C.c · Van de Sompel A.c · Truijen S.a · Van Gaal L.b,c
a Department of Health Sciences – Physiotherapy, University College of Antwerp, b Faculty of Medicine, University of Antwerp, c Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Antwerp, Belgium

Abstract

Aim: To determine the effect of whole body vibration (WBV), combined with caloric restriction, on weight, body composition and metabolic risk factors in overweight and obese adults. Methods: A randomized, controlled study with a 6-month intervention period and a 6-month ‘no intervention’ follow-up. 61 of the 79 participants completed the study. Data were collected at baseline and at 3, 6 and 12 months in the control group (CONTROL), the diet only group (DIET), the diet plus fitness group (FITNESS) and the diet plus WBV group (VIBRATION). Results: Weight decreased significantly in all three intervention groups. Only FITNESS and VIBRATION managed to maintain a weight loss of 5% or more in the long term. Visceral adipose tissue (VAT) changed most in VIBRATION: –47.8 ± 41.2 and –47.7 ± 45.7 cm2 after 6 and 12 months respectively compared to CONTROL (–3.6 ± 20.5 or +26.3 ± 30.6 cm2), DIET (–24.3 ± 29.8 or –7.5 ± 28.3 cm2) and FITNESS (–17.6 ± 36.6 or –1.6 ± 33.3 cm2) (p < 0.001). Conclusions: Combining aerobic exercise or WBV training with caloric restriction can help to achieve a sustained long-term weight loss of 5–10%. These preliminary data show that WBV training may have the potential to reduce VAT more than aerobic exercise in obese adults, possibly making it a meaningful addition to future weight loss programs.

 goto top of outline Author Contacts

Prof. Dr. Luc Van Gaal, Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Wilrijkstraat 10, 2650 Edegem, Belgium, Tel. +32 3 82-13266, Fax -54980, luc.van.gaal@uza.be


 goto top of outline Article Information

Published online: April 7, 2010
Number of Print Pages : 8


 goto top of outline Publication Details

Obesity Facts (The European Journal of Obesity)

Vol. 3, No. 2, Year 2010 (Cover Date: April 2010)

Journal Editor: Hebebrand J. (Essen)
ISSN: 1662-4025 (Print), eISSN: 1662-4033 (Online)

For additional information: http://www.karger.com/OFA


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.